Tivozanib Approval Status
FDA Approved: No
Generic name: tivozanib
Company: AVEO Oncology
Treatment for: Renal Cell Carcinoma
Tivozanib is an investigational tyrosine kinase inhibitor in development for the treatment of advanced renal cell carcinoma.
Development Status and FDA Approval Process for tivozanib
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.